BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8663238)

  • 1. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
    J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
    Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
    J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
    Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
    J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule.
    Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
    Biochemistry; 1996 Nov; 35(47):14743-8. PubMed ID: 8942635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
    Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
    Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the CD6 ligand binding domain.
    Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
    Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of residues in CD6 which are critical for ligand binding.
    Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
    Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
    Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
    Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.
    Bajorath J; Bowen MA; Aruffo A
    Protein Sci; 1995 Aug; 4(8):1644-7. PubMed ID: 8520490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
    Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
    Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
    Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
    Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD6-ligand interactions: a paradigm for SRCR domain function?
    Aruffo A; Bowen MA; Patel DD; Haynes BF; Starling GC; Gebe JA; Bajorath J
    Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
    Bowen MA; Aruffo AA; Bajorath J
    Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
    Nair P; Melarkode R; Rajkumar D; Montero E
    Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD6 recognizes the neural adhesion molecule BEN.
    Skonier JE; Bowen MA; Aruffo A; Bajorath J
    Protein Sci; 1997 Aug; 6(8):1768-70. PubMed ID: 9260290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
    Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
    J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of CD6 function through interaction with Galectin-1 and -3.
    Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
    FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
    Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
    J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells.
    Patel DD; Wee SF; Whichard LP; Bowen MA; Pesando JM; Aruffo A; Haynes BF
    J Exp Med; 1995 Apr; 181(4):1563-8. PubMed ID: 7535342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic activated leukocyte cell adhesion molecule induces CD6
    Qian Q; Cui N; Huang B; Zhao Y; Liu Q; Hu M; Li B; Wang Q; Miao Q; You Z; Ma X; Tang R
    Front Immunol; 2022; 13():967944. PubMed ID: 36159854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.